
S2 Genomics
This company is developing integrated sample preparation systems for processing tissues and liquid samples into genomic samples.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | $16.0m | Series A | |
Total Funding | 000k |
Related Content
S2 Genomics specializes in providing cutting-edge solutions for the preparation of biological samples for genomic analyses. The company focuses on isolating nuclei from formalin-fixed, paraffin-embedded (FFPE) tissue samples and ultra-low volume samples, which are critical for single-cell RNA sequencing (snRNA-Seq). By offering advanced technologies such as the NIR (Nuclei Isolation Reagent) and RNase inhibitor, S2 Genomics serves a diverse clientele including research institutions, biotechnology companies, and healthcare organizations. Operating in the rapidly growing genomics market, the company employs a business model centered around the sale of specialized reagents and consumables, as well as providing technical support and consultation services. Revenue is generated through direct sales and long-term contracts with research entities.
Keywords: Genomics, FFPE, Nuclei Isolation, snRNA-Seq, Biotechnology, Research Institutions, Healthcare, Reagents, Consumables, Technical Support.